Huntington’s Disease News and Research

RSS

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

A group of researchers led by scientists from the Virginia Bioinformatics Institute at Virginia Tech have developed a new technology that detects distinct genetic changes differentiating cancer patients from healthy individuals and could serve as a future cancer predisposition test.

23 Feb 2011

Breakthrough in Huntington's disease may give patients hope for cure

A huge leap forward in understanding Huntington's disease may give patients hope for a cure.

23 Feb 2011

SEIU's allegation concerning malnutrition rates is baseless, say Prime Healthcare hospitals

The February 19, 2011 article written by reporters from California Watch repeats SEIU's allegation that Prime Healthcare hospitals use a diagnosis of malnutrition to increase reimbursement.

22 Feb 2011

dbMotion announces contract awards with numerous healthcare organizations

dbMotion, an innovative provider of connected healthcare solutions, announced contract awards with numerous healthcare organizations including Orlando Health; University Hospitals of Cleveland, Ohio; Sharp Healthcare and Huntington Memorial Hospital in 2010, underscoring the company's accelerated growth among providers seeking to achieve genuinely connected healthcare.

21 Feb 2011

How Huntington's disease proteins move from cell to cell

One bad apple is all it takes to spoil the barrel. And one misfolded protein may be all that's necessary to corrupt other proteins, forming large aggregations linked to several incurable neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's.

19 Feb 2011

Huntington Insurance adds HealthWarehouse.com to prescription drug benefit program

HealthWarehouse.com, Inc., a leading retail mail-order pharmacy, and Huntington Insurance, a wholly-owned subsidiary of Huntington Bancshares Incorporated and leader in employee benefits products, announced today a partnership that will give customers across the Midwest access to low-cost generic prescription medication.

14 Feb 2011

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer's disease and Type 2 diabetes. Their work is published in a recent issue of Nature Chemistry.

10 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation.

2 Feb 2011

Defective nucleoli linked to Parkinson's disease

"Nucleolus", or small nucleus, is the term coined by early biologists for the tiny structure within the nucleus which they saw under the microscope. In this structure within the nucleus, RNA molecules and proteins are assembled to form ribosomes, the true protein factories of cells.

2 Feb 2011

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

The University of Massachusetts Medical School and Lundbeck Inc. today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease.

29 Jan 2011

Research provides new clues for compulsive behavior, cognitive defects linked with LND

Research from the University of California, San Diego School of Medicine provides new clues for the compulsive behavior and cognitive defects associated with a rare childhood neurological disease called Lesch-Nyhan Disease.

29 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

The University of Massachusetts Medical School and Lundbeck today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease.

28 Jan 2011

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases

Protein aggregation underlies several neurodegenerative diseases such as Alzheimer's, Huntington's chorea or Parkinson's. Scientists at the Max Planck Institute of Biochemistry (MPIB) in Martinsried near Munich, Germany, now discovered a fundamental mechanism which explains how toxic protein aggregation occurs and why it leads to a widespread impairment of essential cellular functions.

20 Jan 2011

Huntington’s Disease News and Research

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

Breakthrough in Huntington's disease may give patients hope for cure

SEIU's allegation concerning malnutrition rates is baseless, say Prime Healthcare hospitals

dbMotion announces contract awards with numerous healthcare organizations

How Huntington's disease proteins move from cell to cell

Huntington Insurance adds HealthWarehouse.com to prescription drug benefit program

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

AMRI fourth quarter total revenue increases 12% to $48.6 million

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Defective nucleoli linked to Parkinson's disease

UMMS, Lundbeck announce research collaboration to develop targeted therapy for HD

Research provides new clues for compulsive behavior, cognitive defects linked with LND

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

Scientists discover fundamental mechanism behind toxic protein aggregation in neurodegenerative diseases

MicroRNA-29 molecule makes brain cells resistant to programmed cell death

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Research suggests novel therapeutic approach for Huntington's Disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News